期刊文献+

口服磁共振造影剂枸橼酸铁铵的临床应用 被引量:1

Clinical application of on oral MR contrast agent ferric ammonium citrate
原文传递
导出
摘要 目的探讨枸橼酸铁铵(ferric ammonium citrate,FAC)作为一种口服阴性造影剂在改善磁共振图像质量的应用。方法共收集患者50例,其中20例磁共振胰胆管水成像(MRCP),20例泌尿系统水成像(MRU),10例为盆腔成像。口服枸橼酸铁铵(3 g:600 mg/包)前、后以相同采集参数行磁共振成像,均采用GE 1.5 T磁共振机。并对口服枸橼酸铁铵前、后的图像质量进行比较。结果口服枸橼酸铁铵15 min后行MRCP成像,可有效消除胃、十二指肠内液体对图像的干扰。40 min到1h左右内分2次口服枸橼酸铁铵后行MRU和盆腔成像,可消除部分空肠、回肠、结肠内液体对图像的干扰。结论枸橼酸铁铵作为一种口服阴性造影剂开始逐步应用于临床工作中,可以改善MRCP、MRU及盆腔的图像质量。 Objective To investigate the efficiency of oral ferric ammonium citrate (FAC) as a negative gastrointestinal contrast agent in magnetic resonance imaging. Methods Altogether 50 patients were selected. MRCPwas performed for twenty patients; MRU, for twenty patients; and pelvic MR, for ten patients. Image assessment was based on the difference between non-oral FAC and oral FAC by same parameters. Results MRCP performed 15 minutes after oral FAC could delete effectively interference of liquid in the stomach and duodenum. MRU and pelvic MR performed 40 minutes after oral FAC could delete effectively interference of liquid in the jejunum, ileum and colon. Conclusion The clinical application of oral ferric ammonium citrate as a negative gastrointestinal contrast agent can improve image quality significantly in MRCP, MRU and pelvic MR.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2006年第1期92-93,共2页 Chinese Journal of Radiological Medicine and Protection
关键词 磁共振胰胆管水成像 磁共振泌尿系统水成像 磁共振胃肠道阴性造影剂 口服枸橼酸铁铵 造影剂 MRCP MRU MR negative gastrointestinal contrast agent Oral ferric ammonium citrate
  • 相关文献

参考文献5

二级参考文献13

  • 1Wesbey GE, Brasch RC, Goldberg HI, et al. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging: initial clinical experience[J]. Magn Reson Imaging, 1985, 3(1): 57.
  • 2Patten RM, Moss AA, Fenton TA, et al. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging, safty and imaging characteristics[J]. JMRI, 1992,2(1):25-34.
  • 3Patten RM, Lo SK, Phillips JJ, et al. Positive bowel contrast agent for MR imaging of the abdomen: Phase Ⅱand Ⅲ clinical trials[J]. Radiology, 1993,189(1):227.
  • 4Kivelitz D, Gehl HB, Henck A, et al. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen, safty and diagnostic efficacy[J]. Acta Radiology, 1999,40(4):429.
  • 5Hirohashi S, Uchida H, Tanaka M, et al. Phase Ⅲ study of an oral abdominal contrast agent containing Ferric ammonium citrate for magnestic resonance imaging(OMR-12200)[J]. Diag Treat, 1992,80(3):168.
  • 6Malcolm PN, Brown JJ, Hahn PF, et al. The clinical value of Ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen[J]. JMRI, 2000,12(5):702.
  • 7Yasuhiro O, Yoshihiro N, Kazuo M, et al. Ferric ammonium citrate-cellulose paste for opacification of the esophageal lumen on MRI[J]. Jounal of Computer Assistal Tomography,1996,20(3):455.
  • 8Takahar T, Saeki M, Nosaka S, et al. The use of high concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent:application in MR cholangiography[J]. Nippon Acta Radiol, 1995,55(9):697.
  • 9Takahar T, Yoshikawa T, Saeki M, et al. High concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent[J]. Nippon Igaku Hoshasen Gakkai Zasshi, 1995,55(6):425.
  • 10Hirohashi S, Hirohashi R, Uchida H, et al. MR cholangiography and MR urography:Improved enhancement with a negative oral contrast agent[J]. Radiology, 1997,203(1):281.

共引文献17

同被引文献14

  • 1郭友,陈曌,郑晓林,王金林,何惜金,宁永见,张善譔,胡道予.肝移植术后血管和胆系并发症的MRI诊断价值[J].中华放射学杂志,2005,39(7):718-721. 被引量:8
  • 2严律南.活体肝移植的现状与展望[J].中国普外基础与临床杂志,2007,14(2):128-131. 被引量:23
  • 3Limanond P, Raman SS, Ghobrial RM, et al. The utility of MRCP in preoperative mapping of biliary anatomy in adult-to-adult living related liver transplant donors. J Magn Reson Imaging, 2004, 19:209-215.
  • 4An SK, Lee JM, Suh KS, et al. Gadobenate dimeglumineenhanced liver MRI as the sole preoperative imaging technique: a prospective study of living livet donors. AJR, 2006, 187: 1223-1233.
  • 5Lim JS, Kim MJ, Kim JH, et al. Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine. AJR, 2005, 185:424-431.
  • 6Lee VS, Krinsky GA, Nazzaro CA, et al. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Radiology, 2004, 233 : 659-666.
  • 7Sirvanci M, Duran C, Ozturk E, et al. The value of magnetic resonance cholangiography in the preoperative assessment of living liver donors. Clin Imaging, 2007, 31:401-405.
  • 8Song GW, Lee SG, Hwang S, et al. Preoperative evaluation of biliary anatomy of donor in living donor liver transplantation by conventional nonenhanced magnetic resonance cholangiography. Transpl Int, 2007, 20:167-173.
  • 9Kim RD, Sakamoto S, Haider MA, et al. Role of magnetic resonance cholangiography in assessing biliary anatomy in right lobe living donors. Transplantation, 2005, 79:1417-1421.
  • 10Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol, 2004, 14: 559-578.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部